|Detection of circulating tumor DNA in early-and late-stage human malignancies|
C Bettegowda, M Sausen, RJ Leary, I Kinde, Y Wang, N Agrawal, ...
Science translational medicine 6 (224), 224ra24-224ra24, 2014
|TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal|
PJ Killela, ZJ Reitman, Y Jiao, C Bettegowda, N Agrawal, LA Diaz Jr, ...
Proceedings of the National Academy of Sciences 110 (15), 6021-6026, 2013
|Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder|
Y Gui, G Guo, Y Huang, X Hu, A Tang, S Gao, R Wu, C Chen, X Li, L Zhou, ...
Nature genetics 43 (9), 875-878, 2011
|A community effort to assess and improve drug sensitivity prediction algorithms|
JC Costello, LM Heiser, E Georgii, M Gönen, MP Menden, NJ Wang, ...
Nature biotechnology 32 (12), 1202-1212, 2014
|Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis|
D Theodorescu, S Wittke, MM Ross, M Walden, M Conaway, I Just, ...
The lancet oncology 7 (3), 230-240, 2006
|Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease|
DM Good, P Zürbig, A Argiles, HW Bauer, G Behrens, JJ Coon, M Dakna, ...
Molecular & cellular proteomics 9 (11), 2424-2437, 2010
|Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation|
G Guo, X Sun, C Chen, S Wu, P Huang, Z Li, M Dean, Y Huang, W Jia, ...
Nature genetics 45 (12), 1459-1463, 2013
|Metastasis: a therapeutic target for cancer|
PS Steeg, D Theodorescu
Nature clinical practice Oncology 5 (4), 206-219, 2008
|Clinical proteomics: a need to define the field and to begin to set adequate standards|
H Mischak, R Apweiler, RE Banks, M Conaway, J Coon, A Dominiczak, ...
PROTEOMICS–Clinical Applications 1 (2), 148-156, 2007
|A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery|
JK Lee, DM Havaleshko, HJ Cho, JN Weinstein, EP Kaldjian, J Karpovich, ...
Proceedings of the National Academy of Sciences 104 (32), 13086-13091, 2007
|RhoGDI2 is an invasion and metastasis suppressor gene in human cancer|
JJ Gildea, MJ Seraj, G Oxford, MA Harding, GM Hampton, CA Moskaluk, ...
Cancer research 62 (22), 6418-6423, 2002
|The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations|
Y Ru, KJ Kechris, B Tabakoff, P Hoffman, RA Radcliffe, R Bowler, ...
Nucleic acids research 42 (17), e133-e133, 2014
|Recommendations for biomarker identification and qualification in clinical proteomics|
H Mischak, G Allmaier, R Apweiler, T Attwood, M Baumann, A Benigni, ...
Science translational medicine 2 (46), 46ps42-46ps42, 2010
|TERT promoter mutations and telomerase reactivation in urothelial cancer|
S Borah, L Xi, AJ Zaug, NM Powell, GM Dancik, SB Cohen, JC Costello, ...
Science 347 (6225), 1006-1010, 2015
|Cancer incidence after localized therapy for prostate cancer|
K Moon, GJ Stukenborg, J Keim, D Theodorescu
Cancer: Interdisciplinary International Journal of the American Cancer …, 2006
|Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression.|
I Cornil, D Theodorescu, S Man, M Herlyn, J Jambrosic, RS Kerbel
Proceedings of the National Academy of Sciences 88 (14), 6028-6032, 1991
|Cellular Disposal of miR23b by RAB27-Dependent Exosome Release Is Linked to Acquisition of Metastatic PropertiesExosome miRNAs in Bladder Cancer Metastasis|
MS Ostenfeld, DK Jeppesen, JR Laurberg, AT Boysen, JB Bramsen, ...
Cancer research 74 (20), 5758-5771, 2014
|Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate|
DS Im, CE Heise, MA Harding, SR George, BF O'Dowd, D Theodorescu, ...
Molecular pharmacology 57 (4), 753-759, 2000
|Isolation and identification of potential urinary microparticle biomarkers of bladder cancer|
DM Smalley, NE Sheman, K Nelson, D Theodorescu
Journal of proteome research 7 (5), 2088-2096, 2008
|CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics|
JJ Coon, P Zürbig, M Dakna, AF Dominiczak, S Decramer, D Fliser, ...
Proteomics–Clinical Applications 2 (7‐8), 964-973, 2008